The House Oversight and Government Reform Committee released a report Wednesday suggesting that FDA officials made changes to federal prescription labeling rules to follow a Bush administration policy of protecting drug companies. The report's release comes as the Supreme Court is set to hear arguments Monday in the landmark Wyeth v. Levine pre-emption case. Former FDA Chief Counsel Sheldon Bradshaw says the timing of the report's release is no accident, and its "sole purpose is to sway the Court."
FDA's Ex-Chief Counsel Knocks Timing of Critical Report on Prescription Labeling Rules
The American Lawyer
October 31, 2008